Alpha Cognition Inc. (OTCQB: <a href= "https://www.otcmarkets.com/stock/ACOGF/quote">ACOGF</a>) is a clinical stage, biopharmaceutical company dedicated to developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and ALS. CEO Michael McFadden joins us to break down the types of neurodegenerative diseases that are targeted in the company's programs. <a href= "https://www.otcmarkets.com/files/OTCQBPodcast_AlphaCognition_Season6Episode7.pdf"> View Podcast Transcript for Alpha Cognition</a>

Alpha Cognition Inc. (OTCQB: ACOGF) is a clinical stage, biopharmaceutical company dedicated to developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and ALS. CEO Michael McFadden joins us to break down the types of neurodegenerative diseases that are targeted in the company's programs. View Podcast Transcript for Alpha Cognition

Alpha Cognition Inc. (OTCQB: <a href="https://www.otcmarkets.com/stock/ACOGF/quote" rel="noopener noreferrer">ACOGF</a>) is a clinical stage, biopharmaceutical company dedicated to developing treatments for under-served neurodegenerative diseases, such as Alzheimer's Dementia and ALS. CEO Michael McFadden joins us to break down the types of neurodegenerative diseases that are targeted in the company's programs. <a href="https://www.otcmarkets.com/files/OTCQBPodcast_AlphaCognition_Season6Episode7.pdf" rel="noopener noreferrer"> View Podcast Transcript for Alpha Cognition</a>

Alpha Cognition Inc.

OTC Markets presents our podcast series on the OTCQB Market, where we interview the entrepreneurs behind the companies that trade on the venture market.

Share Alpha Cognition Inc.

Sign up to save your podcasts

Alpha Cognition Inc.

Alpha Cognition Inc.